Therefore, TRPC6-NFATc1 pathway mediated by WNK1-PI4KIIIa through PLC-β signal may play a key role in the tumor growth of ccRCC (30), and this mechanism can provide a potential new target for the treatment of renal cell carcinoma in the future. This evidence concerns the gene TRPC6 and hereditary clear cell renal cell carcinoma.